Latest Articles

Publication Date
Endometrial Cancer Treatment Market Is Going to Boom |• Merck & Co. • Bristol-Myers Squibb - openPR.com

Endometrial Cancer Treatment Market Is Going to Boom |• Merck & Co. • Bristol-Myers Squibb openPR.com

Published: Feb. 11, 2026, 12:24 p.m.
GLP-1s Plus Progestins Tied to Lower Endometrial Cancer Risk - Medscape

GLP-1s Plus Progestins Tied to Lower Endometrial Cancer Risk Medscape

Published: Feb. 11, 2026, 8:49 a.m.
MSK Endometrial Cancer e-Tumor Board - Medscape

MSK Endometrial Cancer e-Tumor Board Medscape

Published: Feb. 10, 2026, 11:06 p.m.
Why is Inoperable Endometrial Cancer Relevant at the 2026 ACRO Summit? - CancerNetwork

Why is Inoperable Endometrial Cancer Relevant at the 2026 ACRO Summit? CancerNetwork

Published: Feb. 10, 2026, 8:43 p.m.
AstraZeneca Imfinzi Approved in India for Endometrial Cancer - Rediff MoneyWiz

AstraZeneca Imfinzi Approved in India for Endometrial Cancer Rediff MoneyWiz

Published: Feb. 10, 2026, 8:42 a.m.
AstraZeneca Pharma India receives CDSCO approval for Durvalumab indication in endometrial cancer - Express Pharma

AstraZeneca Pharma India receives CDSCO approval for Durvalumab indication in endometrial cancer Express Pharma

Published: Feb. 10, 2026, 6:40 a.m.
AstraZeneca Pharma shares gain as it receives CDSCO nod for import of endometrial cancer treatment drug - CNBC TV18

AstraZeneca Pharma shares gain as it receives CDSCO nod for import of endometrial cancer treatment drug CNBC TV18

Published: Feb. 10, 2026, 6:11 a.m.
Advancing Precision: The Vital Role of Biomarker Testing in Endometrial Cancer - Targeted Oncology

Advancing Precision: The Vital Role of Biomarker Testing in Endometrial Cancer Targeted Oncology

Published: Feb. 6, 2026, 10:05 p.m.
How Does Rina-S Work in Patients With Pretreated Endometrial Cancer? - Oncology Nursing News

How Does Rina-S Work in Patients With Pretreated Endometrial Cancer? Oncology Nursing News

Published: Feb. 5, 2026, 5:03 p.m.
GSK’s Jemperli Wins Public Reimbursement in Quebec for Endometrial Cancer Indication - NAVLIN DAILY

GSK’s Jemperli Wins Public Reimbursement in Quebec for Endometrial Cancer Indication NAVLIN DAILY

Published: Feb. 5, 2026, 3:44 a.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!